Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Latest Treatment Updates in Cervical Cancer
Pharmacy Times spoke with Dr. Bradley Monk, investigator for KEYNOTE-826, #LBA2, which was presented at the ESMO Congress 2021, about the study and its importance to the world of cervical cancer.
Pharmacy Times spoke with Dr. Bradley Monk, investigator for KEYNOTE-826, #LBA2, which was presented at the ESMO Congress 2021, about the study and its importance to the world of cervical cancer.
Dr. Monk discussed the highlights of the study, limitations and gaps, and what he feels were the most important findings of the study in the interview.
Related Videos
Related Content
